Supplementary information to the manuscript Reticular Dysgenesis: International Survey on Clinical Presentation,

Transplantation and Outcome
: Bone marrow morphology before HSCT reported in 26 patients with Reticular Dysgenesis.
Abnormalities described in myelopoiesis in addition to promyelocytic developmental arrest include: increased percentage of myeloblasts and signs of dysplastic maturation; abnormalities described in erythropoiesis include: dysplastic maturation, hyper-or hypoplasia; abnormal megakaryopoiesis was described as: hyperplasia and dysplastic maturation with micromegakaryocytes. ; CSA: cyclosporine A; MTX: methotrexate; MMF: mycophenolate mofetil; T only: only T cells of donor origin were detected; pre: GvHD was present before transplantation and is most probably due to an alloreaction caused by persisting maternal cells; MDS: myelodysplastic syndrome; VOD: venoocclusive disease; *busulfan dosage given in mg/m 2 ; **treosulfan dosage given in mg/kg; ***targeted Bu 800-1200 µmol*min/L; 
